🇺🇸 FDA
Patent

US 9119823

Nitrite formulations and their use as nitric oxide prodrugs

granted A61KA61K31/195A61K31/198

Quick answer

US patent 9119823 (Nitrite formulations and their use as nitric oxide prodrugs) held by The Board of Regents of the University of Texas System expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/195, A61K31/198, A61K31/375, A61K31/714